TSX:CRON (Cronos Group)
About CRON
Cronos Group seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada’s Marihuana for Medical Purposes Regulations (“MMPR”).
Cronos Group (TSX: CRON) Latest News

Cannabis Stocks
Why Cronos Group (TSX:CRON) Is Still Too Expensive, Even at $14/Share

Stocks for Beginners
3 High-Growth Stocks Poised to Soar in the Next Year

Cannabis Stocks
Forget Canopy Growth (TSX:WEED): Buy These 3 Pot Stocks Instead

Cannabis Stocks
Is Cronos (TSX:CRON) Attractive After a Recent Pullback?

Cannabis Stocks
Cronos (TSX:CRON) Shares Tank, But is it Now a Buy?

Cannabis Stocks
How to Invest Without Getting Burned: A Tale of 2 Cannabis Earnings

Cannabis Stocks
3 Reasons Cronos Group’s (TSX:CRON) Q2 Results Aren’t Enough to Make the Stock a Buy

Cannabis Stocks
Has the Pot Stock Bubble Finally Burst?

Stocks for Beginners
Should Cannabis Investors Buy Into the Biosynthesis Hype?

Cannabis Stocks
How Canopy Growth (TSX:WEED) Overshadowed Cronos (TSX:CRON) Earnings

Cannabis Stocks
Is the Lord Jones Acquisition the Right Move for Cronos Group (TSX:CRON)?
